Clinical trial
Prospective, Multicenter, 60 Months, Single-arm Cohort Trial for Evaluation of the Efficacy and Safety of Transvaginal Sacrospinous Ligament Fixation With Splentis for the Treatment of Primary Apical Pelvic Organ Prolapse
NCT05042453 is registered in ClinicalTrials.gov with Promedon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Multicenter, 60 Months, Single-arm Cohort Trial for Evaluation of the Efficacy and Safety of Transvaginal Sacrospinous Ligament Fixation With Splentis for the Treatment of Primary Apical Pelvic Organ Prolapse
- Lead sponsor
- Promedon
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 19, 2022
- Completion date
- July 31, 2030
- Enrollment
- 140 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.